In this March 31, 2020 file photo, a woman pulls groceries from a cart to her vehicle outside of a Walmart store in Pearl, Miss. Walmart is teaming with the General Motors' Cruise autonomous vehicle unit to test automated package delivery in Arizona. (AP Photo/Julio Cortez, File)
By Michael Balsamo and Ann D'Innocenzio
The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.
The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.
The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.
Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.
“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”
The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.
AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.
The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.
In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.
Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.
The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.
Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.
Updated on December 22, 2020, at 3:44 p.m. ET with additional details.
Digital mental health company Little Otter recently announced it closed a $22 million Series A round. Little Otter was founded in 2020 by a mother-daughter team, which based the company on the idea that a child's mental health can only be addressed by treating the whole family through technology available to everyone. Little Otter CEO and co-founder Rebecca Egger and her mother, Little Otter Chief Medical and Scientific Officer and co-founder Dr. Helen Egger joined Cheddar News' Closing Bell to discuss.
Stocks closed lower Thursday with the tech-heavy Nasdaq in particular under pressure as investors dump tech stocks amid interest rate hike fears. This is the third session in a row that the Nasdaq has slipped. Meanwhile, rate-sensitive stocks gained one day after the Federal Reserve announced its more hawkish policy including three rate hikes this year. Kristina Hooper, Chief Global Market Strategist at Invesco, joins Cheddar News' Closing Bell to discuss today's close, this week's Fed minutes and the central bank's new hawkish policy, and more.
Jared Watkin, senior vice president, diabetes care, at Abbott Laboratories, joined Michelle Castillo from the CES 2022 floor to discuss the future of health tech, including Abbott's consumer-facing biowearable called Lingo. The accessory is supposed to send real-time biomarker information like glucose or ketone levels to the Lingo app for the wearer to review. "The idea is that it's a window into your body," Watkin said. "It gives you insight into what's going on in your body and the certain circumstances that you otherwise wouldn't be able to have."
Aaron Jefferson, VP of product at Luminar, joined Cheddar to discuss partnering with automaker Volvo to bring its LIDAR (light detection and ranging) tech into autonomous cars capable of safely driving on the highway. While companies like Tesla have come under fire due to safety issues with its self-driving technology, Jefferson noted how his company's tech differs. "Our LIDAR, its iris sensor that's really set for production, is able to sense, understand, and give the vehicle confidence to react accordingly such that you don't have these same types of issues," he said. The Ride Pilot technology in Volvo vehicles will be rolled out in California following safety testing.
The fintech app backed by billionaire Mark Cuban called Dave made its public debut on the Nasdaq Thursday via a SPAC merger. CEO and co-founder Jason Wilk spoke to Cheddar's Kristen Scholer about the IPO and how his company's services distinguish it from traditional banks. "Customers come to us because they're tired of paying $20 billion of overdraft fees, and they come to Dave, they download our app, and within minutes they can get access to $250 of no interest credit, which we give them through our own proprietary machine learning model," he told Cheddar.
Stephanie Linnartz, president of Marriott International, joined Cheddar's "Closing Bell" to talk about the launch of the Marriott Design Lab, a new facility within its Bethesda, Maryland, headquarters to explore innovative tech offerings for bolstering the guest experience. "It's all around figuring out how we can innovate in the guest room in the public space, looking at how we can use robotics, improve sustainability, etcetera," she said. Some short-term changes in the future Linnartz also noted is an expansion of the chain's mobile capabilities to make check-in and check-out an easier process for guests, as well as mobile room service, from the feedback it received during the pandemic.
Nike has initiated a lawsuit against athletic apparel retailer and competitor Lululemon over claims of patent infringement. The sneaker giant is claiming the technology in their rival's MIRROR home gym was patented back in 1983.
Adi Robertson, senior reporter at The Verge, joins Cheddar News to break down the battle between two NFT collections by Phunky Ape Yacht Club and PHAYC that are selling plagiarized Bored Ape Yacht Club designs.
Following the attack on the Capitol last year, several major corporations promised to no longer pour funds into the campaigns of Republican lawmakers who supported the January 6 insurrection. But not all have stood firm on their word. Among those that did keep to their promise were Nike, American Express, and Walgreens.
